153 related articles for article (PubMed ID: 11095181)
1. Divergent solid-phase synthesis and candidacidal activity of MUC7 D1, a 51-residue histidine-rich N-terminal domain of human salivary mucin MUC7.
Satyanarayana J; Situ H; Narasimhamurthy S; Bhayani N; Bobek LA; Levine MJ
J Pept Res; 2000 Nov; 56(5):275-82. PubMed ID: 11095181
[TBL] [Abstract][Full Text] [Related]
2. Candidacidal activity prompted by N-terminus histatin-like domain of human salivary mucin (MUC7)1.
Gururaja TL; Levine JH; Tran DT; Naganagowda GA; Ramalingam K; Ramasubbu N; Levine MJ
Biochim Biophys Acta; 1999 Apr; 1431(1):107-19. PubMed ID: 10209284
[TBL] [Abstract][Full Text] [Related]
3. In vitro assessment of antifungal therapeutic potential of salivary histatin-5, two variants of histatin-5, and salivary mucin (MUC7) domain 1.
Situ H; Bobek LA
Antimicrob Agents Chemother; 2000 Jun; 44(6):1485-93. PubMed ID: 10817697
[TBL] [Abstract][Full Text] [Related]
4. Human salivary MUC7 mucin peptides: effect of size, charge and cysteine residues on antifungal activity.
Situ H; Wei G; Smith CJ; Mashhoon S; Bobek LA
Biochem J; 2003 Oct; 375(Pt 1):175-82. PubMed ID: 12812519
[TBL] [Abstract][Full Text] [Related]
5. Studies of the mechanism of human salivary histatin-5 candidacidal activity with histatin-5 variants and azole-sensitive and -resistant Candida species.
Tsai H; Bobek LA
Antimicrob Agents Chemother; 1997 Oct; 41(10):2224-8. PubMed ID: 9333052
[TBL] [Abstract][Full Text] [Related]
6. MUC7 20-Mer: investigation of antimicrobial activity, secondary structure, and possible mechanism of antifungal action.
Bobek LA; Situ H
Antimicrob Agents Chemother; 2003 Feb; 47(2):643-52. PubMed ID: 12543672
[TBL] [Abstract][Full Text] [Related]
7. The recombinant N-terminal region of human salivary mucin MG2 (MUC7) contains a binding domain for oral Streptococci and exhibits candidacidal activity.
Liu B; Rayment SA; Gyurko C; Oppenheim FG; Offner GD; Troxler RF
Biochem J; 2000 Feb; 345 Pt 3(Pt 3):557-64. PubMed ID: 10642514
[TBL] [Abstract][Full Text] [Related]
8. Human salivary mucin MUC7 12-mer-L and 12-mer-D peptides: antifungal activity in saliva, enhancement of activity with protease inhibitor cocktail or EDTA, and cytotoxicity to human cells.
Wei GX; Bobek LA
Antimicrob Agents Chemother; 2005 Jun; 49(6):2336-42. PubMed ID: 15917530
[TBL] [Abstract][Full Text] [Related]
9. Stabilization of helix by side-chain interactions in histatin-derived peptides: role in candidacidal activity.
Ramalingam K; Gururaja TL; Ramasubbu N; Levine MJ
Biochem Biophys Res Commun; 1996 Aug; 225(1):47-53. PubMed ID: 8769093
[TBL] [Abstract][Full Text] [Related]
10. Role of alpha-helical conformation of histatin-5 in candidacidal activity examined by proline variants.
Situ H; Balasubramanian SV; Bobek LA
Biochim Biophys Acta; 2000 Jul; 1475(3):377-82. PubMed ID: 10913839
[TBL] [Abstract][Full Text] [Related]
11. Construction and characterization of human salivary histatin-5 multimers.
Situ H; Tsai H; Bobek LA
J Dent Res; 1999 Feb; 78(2):690-8. PubMed ID: 10029468
[TBL] [Abstract][Full Text] [Related]
12. Salivary histatin 5: dependence of sequence, chain length, and helical conformation for candidacidal activity.
Raj PA; Edgerton M; Levine MJ
J Biol Chem; 1990 Mar; 265(7):3898-905. PubMed ID: 2406266
[TBL] [Abstract][Full Text] [Related]
13. In vitro synergic antifungal effect of MUC7 12-mer with histatin-5 12-mer or miconazole.
Wei GX; Bobek LA
J Antimicrob Chemother; 2004 May; 53(5):750-8. PubMed ID: 15073161
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of human salivary mucin MUC7-derived peptide and histatin 5 in a murine model of candidiasis.
Intini G; Aguirre A; Bobek LA
Int J Antimicrob Agents; 2003 Dec; 22(6):594-600. PubMed ID: 14659657
[TBL] [Abstract][Full Text] [Related]
15. Proteomic and metabolic characterization of a Candida albicans mutant resistant to the antimicrobial peptide MUC7 12-mer.
Lis M; Bobek LA
FEMS Immunol Med Microbiol; 2008 Oct; 54(1):80-91. PubMed ID: 18680518
[TBL] [Abstract][Full Text] [Related]
16. Solution structure of O-glycosylated C-terminal leucine zipper domain of human salivary mucin (MUC7).
Narasimhamurthy S; Naganagowda GA; Janagani S; Gururaja TL; Levine MJ
J Biomol Struct Dyn; 2000 Aug; 18(1):145-54. PubMed ID: 11021659
[TBL] [Abstract][Full Text] [Related]
17. Factors affecting antimicrobial activity of MUC7 12-mer, a human salivary mucin-derived peptide.
Wei GX; Campagna AN; Bobek LA
Ann Clin Microbiol Antimicrob; 2007 Nov; 6():14. PubMed ID: 17996119
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and conformational features of human salivary mucin C-terminal derived peptide epitope carrying Thomsen-Friedenreich antigen: implications for its role in self-association.
Satyanarayana J; Gururaja TL; Narasimhamurthy S; Naganagowda GA; Levine MJ
Biopolymers; 2001 Apr; 58(5):500-10. PubMed ID: 11241221
[TBL] [Abstract][Full Text] [Related]
19. Membrane-induced helical conformation of an active candidacidal fragment of salivary histatins.
Raj PA; Soni SD; Levine MJ
J Biol Chem; 1994 Apr; 269(13):9610-9. PubMed ID: 8144548
[TBL] [Abstract][Full Text] [Related]
20. Large-scale synthesis and functional elements for the antimicrobial activity of defensins.
Raj PA; Antonyraj KJ; Karunakaran T
Biochem J; 2000 May; 347 Pt 3(Pt 3):633-41. PubMed ID: 10769165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
